The Structural Genomics Consortium Standardizes on RoboDesign® International, Inc.'s CrystalMation™ Platform

The Structural Genomics Consortium Standardizes on RoboDesign® International, Inc.'s CrystalMation™ Platform

Carlsbad, CA and The Woodlands, TX — April 6, 2004. RoboDesign International, Inc., through its worldwide marketing partner, Rigaku. announced that the Structural Genomics Consortium (SGC) has chosen CrystalMation™ as its standard protein crystal imaging and analysis technology. CrystalMation is a fully modular and automated protein crystallization platform, which includes systems for liquid handling, low volume dispense, imaging, storage and analysis.

The SGC will be utilizing the Minstrel III and RoboIncubator combinations for its high throughput crystallography facility. With its high-resolution imaging system, programmable lighting system, and RoboDesign's patent-pending image processing method, the Minstrel HT was specifically designed to address the unique challenges to protein drop imaging. As with all of the CrystalMation components, the Minstrel HT was designed to be expandable and modular. It can be expanded with multiple RoboIncubators and a wide array of software tools. Delivery of the first systems to the University of Oxford will be in May 2004.

"We are pleased and excited to support the SGC through the installation of CrystalMation," said Robert L. Corey, president and CEO of RoboDesign. "The SGC's goal of determining 200 protein structures per year absolutely requires automation that can address the bottlenecks associated with traditional methods of crystallization. We believe that our CrystalMation platform does just that by revolutionizing the way and speed in which crystallization is performed."

About Structural Genomics Consortium

SGC is a not-for-profit organization that aims to determine the three dimensional structures of proteins of medical relevance, and place them in the public domain without restriction. The goal is to develop the infrastructure and technologies necessary for rapid, parallel, structure determination, with the aim of having the capability to determine 200 protein structures per year. The structural information generated by SGC is expected to have a tremendous impact on human health by furthering the understanding of relevant proteins and by supplying new targets for therapeutic interventions. It will also provide the structural framework for the rational design of new or improved drugs that can inhibit or enhance protein function.

About RoboDesign® International, Inc.

RoboDesign International, Inc. is the premier source for development, design, and manufacture of automation solutions and instrumentation for the life sciences industry. RoboDesign offers standard as well as custom products for drug discovery and laboratory and hospital automation. With its broad range of technical expertise, RoboDesign is uniquely positioned to provide a wide array of engineering services, from rapid prototyping to OEM design and manufacturing. From fully automated pharmacy systems to protein crystal imaging and analysis, RoboDesign's enabling technologies are playing a vital role in all phases of the fight against disease.

Rigaku—Leading With Innovation

Since its inception in Japan in 1951, Rigaku has been at the forefront of analytical and industrial instrumentation technology. Rigaku and its subsidiaries form a global group focused on life sciences and general purpose analytical instrumentation. With hundreds of major innovations to their credit, Rigaku companies are world leaders in the fields of small molecule and protein crystallography, X-ray spectrometry and diffraction, X-ray optics, as well as semiconductor metrology. Rigaku employs over 1,100 people in the manufacture and support of its analytical equipment. Its products are in use in more than 70 countries—supporting research, development, and quality assurance activities. Throughout the world, Rigaku continuously promotes partnerships, dialog, and innovation within the global scientific and industrial community.

For further information, contact:

Joseph D. Ferrara, Ph.D.
VP Product Marketing and CSO
Rigaku Americas Corporation
Tel: (281) 362-2300
eMail: Joseph D. Ferrara